Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Circulation: Heart Failure
Journal
Overview
Identity
Overview
Publication Venue For
Inflammation and Circulating Natriuretic Peptide Levels
. 13:135-144.
2020
Assessment of Heterogeneity in Heart Failure-Related Meta-Analyses
. 655-659.
2020
Association of Sedentary Time and Incident Heart Failure Hospitalization in Postmenopausal Women
. 757-766.
2020
Lower Rates of Heart Failure and All-Cause Hospitalizations during Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes from the CardioMEMS Post-Approval Study
. 229-238.
2020
Polypharmacy in Older Adults Hospitalized for Heart Failure
. 577-588.
2020
Prognostic Awareness and Goals of Care Discussions among Patients with Advanced Heart Failure
. 326-333.
2020
Characteristics and healthcare utilization among veterans treated for heart failure with reduced ejection fraction who switched to sacubitril/valsartan
. 12.
2019
Intra-aortic Balloon Pump As a Bridge to Heart Transplant after Non-ST-Segment-Elevation Myocardial Infarction in Palliated Hypoplastic Left Heart Syndrome
. 12.
2019
Prevalence of American Heart Association Heart Failure Stages in Black and White Young and Middle-Aged Adults: The CARDIA Study
. 12.
2019
IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure
. 11:e005133.
2018
Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial
. 11:e004457.
2018
Predicting Risk in Patients Hospitalized for Acute Decompensated Heart Failure and Preserved Ejection Fraction: The Atherosclerosis Risk in Communities Study Heart Failure Community Surveillance
. 10.
2017
Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis
. 10.
2017
Myocardial Upregulation of Cathepsin D by Ischemic Heart Disease Promotes Autophagic Flux and Protects Against Cardiac Remodeling and Heart Failure
. 10.
2017
Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial
. 10.
2017
Activated T lymphocytes are essential drivers of pathological remodeling in ischemic heart failure
. 10.
2017
Intracardiac Pressures Measured Using an Implantable Hemodynamic Monitor: Relationship to Mortality in Patients with Chronic Heart Failure
. 10.
2017
Dying with a Left Ventricular Assist Device as Destination Therapy
. 9.
2016
Association of weight and body composition on cardiac structure and function in the ARIC study (Atherosclerosis Risk in Communities)
. 9.
2016
Pulmonary Artery Pressure-Guided Heart Failure Management Reduces 30-Day Readmissions
. 9.
2016
Heart failure and midrange ejection fraction
. 9.
2016
Prognostic relevance of left atrial dysfunction in heart failure with preserved ejection fraction
. 9.
2016
Clinical Characteristics and Outcomes of Intravenous Inotropic Therapy in Advanced Heart Failure
. 8:880-886.
2015
Duration of Heart Failure Is an Important Predictor of Outcomes after Mechanical Circulatory Support
. 8:953-959.
2015
Response to Letter Regarding Article, "cardiac Structure and Function Across the Glycemic Spectrum in Elderly Men and Women Free of Prevalent Heart Disease: The Atherosclerosis Risk in the Community Study"
. 8:1010.
2015
Alcohol and Incident Heart Failure among Middle-Aged and Elderly Men: Cohort of Swedish Men
. 8:422-427.
2015
Cardiac Structure and Function Across the Glycemic Spectrum in Elderly Men and Women Free of Prevalent Heart Disease: The Atherosclerosis Risk in the Community Study
. 8:448-454.
2015
Central cardiac limit to aerobic capacity in patients with exertional pulmonary venous hypertension: Implications for heart failure with preserved ejection fraction
. 8:278-285.
2015
Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the veterans affairs versus other hospitals insights from the Beta-blocker Evaluation of Survival Trial (BEST)
. 8:17-24.
2015
Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast
. 8:156-166.
2015
Discharge hospice referral and lower 30-day all-cause readmission in medicare beneficiaries hospitalized for heart failure
. 8:733-740.
2015
E/e′ ratio in patients with unexplained dyspnea lack of accuracy in estimating left ventricular filling pressure
. 8:749-756.
2015
Effects of intracoronary infusion of escalating doses of cardiac stem cells in rats with acute myocardial infarction
. 8:757-765.
2015
Heart Failure Management in Skilled Nursing Facilities: A Scientific Statement from the American Heart Association and the Heart Failure Society of America
. 8:655-687.
2015
Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone
. 8:1052-1058.
2015
Prognostic Significance of Depression in Blacks with Heart Failure: Insights from Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training
. 8:497-503.
2015
Risk of heart failure among postmenopausal women a secondary analysis of the randomized trial of Vitamin D plus calcium of the women's health initiative
. 8:49-56.
2015
Risk of heart failure and death after prolonged smoking cessation: Role of amount and duration of prior smoking
. 8:694-701.
2015
Transitions of care in heart failure: A scientific statement from the American heart association
. 8:384-409.
2015
Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction
. 7:935-944.
2014
Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction
. 7:945-952.
2014
Cardiac structure and function and prognosis in heart failure with preserved ejection fraction
. 7:740-751.
2014
Cardiac structure and function in heart failure with preserved ejection fraction: Baseline findings from the echocardiographic study of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial
. 7:104-115.
2014
Elevation in high-sensitivity troponin t in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696
. 7:953-959.
2014
Increased sarcolipin expression and adrenergic drive in humans with preserved left ventricular ejection fraction and chronic isolated mitral regurgitation
. 7:194-202.
2014
Left atrial volume and the benefit of cardiac resynchronization therapy in the MADIT-CRT Trial
. 7:154-160.
2014
Metabolomic analysis of pressure-overloaded and infarcted mouse hearts
. 7:634-642.
2014
Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction
. 6:508-516.
2013
Right ventricular function, pulmonary pressure estimation, and clinical outcomes in cardiac resynchronization therapy
. 6:435-442.
2013
Mediterranean and DASH diet scores and mortality in women with heart failure the women s health initiative
. 6:1116-1123.
2013
Response to letter regarding article, habitual coffee consumption and risk of heart failure: A dose-response meta-analysis
. 5.
2012
Anisotropic reinforcement of acute anteroapical infarcts improves pump function
. 5:515-522.
2012
Habitual coffee consumption and risk of heart failure a dose-response meta-analysis
. 5:401-405.
2012
Coffee consumption and incidence of heart failure in women
. 4:414-418.
2011
Dyssynchrony, contractile function, and response to cardiac resynchronization therapy
. 4:433-440.
2011
Response to letter regarding article, "chocolate intake and incidence of heart failure: A population-based, prospective study of middle-aged and elderly women"
. 4.
2011
Chocolate intake and incidence of heart failure a population-based prospective study of middle-aged and elderly women
. 3:612-616.
2010
Chronic ambulatory intracardiac pressures and future heart failure events
. 3:580-587.
2010
Editorial: Can vitamin D supplementation improve physical function and quality of life in older patients with heart failure?
. 3:183-184.
2010
Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease findings from propensity-matched studies
. 3:253-260.
2010
Effects of peripheral arterial disease on outcomes in advanced chronic systolic heart failure a propensity-matched study
. 3:118-124.
2010
α1-adrenergic receptor subtypes in nonfailing and failing human myocardium
. 2:654-663.
2009
Adiposity and incidence of heart failure hospitalization and mortality: A population-based prospective study
. 2:202-208.
2009
Reduction in mitral regurgitation during therapy guided by measured filling pressures in the ESCAPE trial
. 2:181-188.
2009
Mechanical circulatory support: registering a therapy in evolution.
. 1:200-205.
2008
Identity
International Standard Serial Number (issn)
1941-3289
Electronic International Standard Serial Number (eissn)
1941-3297